Chiasma Expands Management Team
This article was originally published in Scrip
Chiasma, Inc. has appointed Tara McCarthy senior vice president and general counsel and Steven Vickers vice president of sales. Most recently, McCarthy was vice president of commercial law for Vertex Pharmaceuticals and prior to this, she was senior corporate counsel at Genzyme Corporation. Vickers recently was senior national sales director for Onyx Pharmaceuticals' hematology business. Before this he was sales leader at Millennium Pharmaceuticals, Eisai Incorporated and Chiron Corporation.
You may also be interested in...
How to make the most of the wealth of raw data in pharmaceutical R&D is an increasing challenge for the industry. The digital revolution is already having an impact in areas like clinical trials, and pharma is also starting to embrace new technologies in drug discovery.
Technology advancement has brought a wave of change in healthcare, with an increasing number of key pharma players now recognizing the potential of digital – particularly in clinical trials.
This week's roundup includes high-level appointments by Five Prime Therapeutics, Depomed and Gilead Sciences and board appointments by Verseon, Arix Bioscience, and Corbus Pharmaceuticals.